Novo Integrated Sciences, Inc. (NVOS) Comparison with companies in other sectors?

Novo Integrated Sciences, Inc. has a share price of 19.73M. You can analyze Novo Integrated Sciences, Inc. (NVOS) competitors across different market sectors through stock heatmaps.

What are NVOS's NET and operating margins?

Novo Integrated Sciences, Inc. (NVOS) operating margin is around -0.72, and net profit margin is approximately -2.07 as of the latest reports.

In what way does NVOS's earnings per share (EPS) trend reflect its financial momentum?

Novo Integrated Sciences, Inc. (NVOS) EPS is -1.33 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Novo Integrated Sciences, Inc. is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Novo Integrated Sciences, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Novo Integrated Sciences, Inc. like P/E which is -0.00, P/B which is 0.004, and PEG which is 0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Novo Integrated Sciences, Inc.

NVOS•NASDAQ

Healthcare

Medical - Care Facilities

$0.003

$-0.00(-15.38%)

Fundamental Analysis of Novo Integrated Sciences, Inc. (NVOS)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-1.33

P/E Ratio

ROE

-1.20%

Net Margin

-2.07%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$65.11K

Shares OutstandingTotal number of shares issued

$19.73M

Book Value/ShareNet worth per share

$0.78

Revenue/ShareAnnual revenue per share

$0.55

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-1.33

Net MarginNet income as percentage of revenue

-207.26%

Operating MarginOperating income as percentage of revenue

-72.23%

ROEReturn on shareholders' equity

-119.90%

ROAReturn on total assets

-65.86%

ROCEReturn on capital employed

-42.01%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.24

Cash/ShareCash and equivalents per share

$0.05

FCF YieldFree cash flow as percentage of market cap

-6951.20%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for NVOSFinancial Ratios Analysis details for NVOS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for NVOSSector Benchmarking details for NVOS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Novo Integrated Sciences, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Novo Integrated Sciences, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Novo Integrated Sciences, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Novo Integrated Sciences, Inc.

For Novo Integrated Sciences, Inc., essential financial indicators include EPS -1.33, PE -, and ROE -1.20. These key ratios reveal insights into Novo Integrated Sciences, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Novo Integrated Sciences, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Novo Integrated Sciences, Inc.

Metrics like Net Margin -207.26% and ROA -65.86% shed light on how well Novo Integrated Sciences, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Novo Integrated Sciences, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Novo Integrated Sciences, Inc.

Using ratios such as P/B Ratio 0.004 and PEG Ratio 0.00, investors can assess whether Novo Integrated Sciences, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Novo Integrated Sciences, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Novo Integrated Sciences, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.32 and Cash Flow $-0.24, provide a snapshot of Novo Integrated Sciences, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Novo Integrated Sciences, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Novo Integrated Sciences, Inc.

Investing in Novo Integrated Sciences, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Novo Integrated Sciences, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;